CM Life Sciences (Digital)
December 3, 2020
twoXAR Pharmaceuticals CEO Andrew A. Radin joins a webinar hosted by CM Life Sciences to discuss harnessing AI in drug discovery.
EPPIC Global (Digital)
October 17, 2020
twoXAR Pharmaceuticals SVP Nonclinical R&D & Chemistry Anjali Pandey moderates a panel including twoXAR CEO Andrew Radin, along with representatives from Recursion Pharma, ATOM Consortium, and NuMedii.
MIT ILP (Digital)
October 16, 2020
twoXAR Pharmaceuticals CEO Andrew Radin presents on the company's capabilities in discovering first-in-class small molecules for oncology and more using AI.
October 1, 2020
twoXAR Pharmaceuticals CEO Andrew A. Radin presents and joins the JLabs Panel to discuss how biology startups can partner with AI companies.
July 14, 2020
Andrew A. Radin, CEO - TEDMED 2016
WEBINARS, PODCASTS & VIDEOS
AI in BioPharma
July 14, 2020
twoXAR CEO Andrew Radin joins the Executive Viewpoints Panel: Using AI Effectively from R&D to Patient Care - Critical Technical and People Issues
June 18, 2020
Vibeke Strand, MD, MACR, FACP, Adjunct Clinical Professor in the Division of Immunology/ Rheumatology professor at Stanford University School of Medicine, discusses twoXAR's research in her field and patients who are having a hard time getting their usual supplies of HCQ during the COVID-19 pandemic.